Cargando…
Impact of the COVID-19 pandemic on the incidence and type of infections in hospitalized patients with cirrhosis
Autores principales: | Cuyas, Berta, Huerta, Anna, Poca, Maria, Alvarado-Tapias, Edilmar, Brujats, Anna, Roman, Eva, Guarner, Carlos, Escorsell, Àngels, Soriano, German |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252393/ http://dx.doi.org/10.1016/S0168-8278(22)02090-6 |
Ejemplares similares
-
Bile duct‐ligated mice exhibit multiple phenotypic similarities to acute decompensation patients despite histological differences
por: O'Brien, Alastair, et al.
Publicado: (2015) -
COVID-19 in patients with cirrhosis: insights from the multinational LEOSS registry
por: Brozat, Jonathan Frederik, et al.
Publicado: (2022) -
Use of Tocilizumab in patients with stable chronic liver disease and severe COVID-19 for prevention of decompensated cirrhosis, a prospective, open-label, randomized controlled trial.
por: Rosales Renteria, Luis Alejandro, et al.
Publicado: (2022) -
SARS-CoV-2 infection in patients with underlying chronic liver disease is associated with significantly greater risks of inpatient hospitalization, intensive care unit admission, and overall mortality
por: Wong, Robert, et al.
Publicado: (2022) -
Phase angle by electrical bioimpedance is a predictive factor of hospitalisation, falls and mortality in patients with cirrhosis
por: Román, Eva, et al.
Publicado: (2021)